Meta's $14.8 billion Scale AI deal latest test of AI partnerships

Meta's $14.8 billion investment in Scale AI, granting it a 49% nonvoting stake and bringing Scale AI's CEO to Meta, is under scrutiny for potentially evading antitrust regulations, particularly regarding "acquihires." While the deal avoids immediate regulatory review, concerns exist about its impact on competition, with Google already severing ties with Scale AI; regulatory action remains uncertain, influenced by the Trump administration's approach to AI partnerships and ongoing antitrust probes into similar tech deals.

Analysis

Meta Platforms' $14.8 billion investment for a 49% nonvoting stake in data-labeling firm Scale AI, coupled with the hiring of Scale's CEO Alexandr Wang, represents a significant move to bolster its AI capabilities but simultaneously navigates a complex regulatory landscape. This deal, Meta's second-largest, is structured to avoid mandatory U.S. antitrust review; however, it has drawn immediate attention for potentially circumventing scrutiny of "acquihire" arrangements, with regulators retaining the option to investigate if competitive harm or evasion is suspected, a concern amplified by Senator Elizabeth Warren's call for a probe. The competitive ramifications are already materializing, as Alphabet's Google has reportedly decided to terminate its relationship with Scale AI following Meta's investment, signaling potential customer defections despite Scale AI's assurances of data protection for its clientele, which includes Microsoft and OpenAI. The regulatory environment under the Trump administration is perceived by some as potentially more lenient towards AI partnerships than the Biden administration, though a general suspicion of large tech platforms persists, evidenced by ongoing Department of Justice and Federal Trade Commission inquiries into AI deals by Google, Microsoft, and Amazon. Notably, some past FTC inquiries, such as into Amazon's AI startup Adept talent acquisition and Microsoft's $650 million Inflection AI deal, have yet to result in decisive enforcement action, although a broader probe into Microsoft is ongoing. Meta itself is already contending with an FTC monopoly lawsuit, adding another layer of uncertainty to the outcome and implications of this strategic AI investment.

Key Decisions for Investors

• For Meta (META) investors, the strategic AI enhancement via the $14.8 billion Scale AI investment is accompanied by substantial regulatory scrutiny and the risk of customer erosion at Scale AI, potentially impacting the deal's ultimate value and warranting close observation of antitrust developments.
• Investors in Alphabet (GOOGL) should consider the potential for increased AI development costs or operational adjustments due to its disengagement from Scale AI, alongside the ongoing regulatory examination of Google's own AI collaborations, which contributes to a more cautious outlook for its AI execution.
• Given the pronounced regulatory focus on AI partnerships across Big Tech, investors should anticipate continued uncertainty and potential challenges for deals structured as minority stakes or 'acquihires', warranting a cautious approach to related exposures until greater policy clarity emerges.
• Monitoring pronouncements from the FTC and DOJ regarding investigations into Meta's Scale AI deal, as well as similar arrangements involving Microsoft (MSFT) and Google (GOOGL), is critical for assessing the evolving risk landscape and permissibility of strategic AI investments in the sector.